CY1106088T1 - Παραγωγα στepοειδων του 3-μεθυλενιου για θepαπεια αυτοανοσων παθησεων - Google Patents

Παραγωγα στepοειδων του 3-μεθυλενιου για θepαπεια αυτοανοσων παθησεων

Info

Publication number
CY1106088T1
CY1106088T1 CY20061100629T CY061100629T CY1106088T1 CY 1106088 T1 CY1106088 T1 CY 1106088T1 CY 20061100629 T CY20061100629 T CY 20061100629T CY 061100629 T CY061100629 T CY 061100629T CY 1106088 T1 CY1106088 T1 CY 1106088T1
Authority
CY
Cyprus
Prior art keywords
treatment
autoimmune diseases
methylene
stepoide
derivatives
Prior art date
Application number
CY20061100629T
Other languages
English (en)
Inventor
Ralf Plate
Wilhelmina Maria Bagchus
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of CY1106088T1 publication Critical patent/CY1106088T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αφορά σε ένα παράγωγο του στεροειδούς 3-μεθυλενίου που έχει το γενικό τύπο 1 όπου R1 είναι Η ή μαζί με R3 σχηματίζει ένα β-εποξείδιο ή R1 απουσιάζει εάν υπάρχει ένας 5-10 ή 4-5 διπλός δεσμός. R2 είναι (C1-C5)alkyl ή CF3. R3 είναι βΗ, βCΗ3 ή μαζί με R1 σχηματίζει ένα β-εποξείδιο ή R3 απουσιάζει εάν υπάρχει ένας 5-10 διπλός δεσμός. R4 είναι Η, χαμηλότερο αλκύλιο. Υ είναι [Η, Η] [ΟΗ, Η], =O, [ΟΗ, χαμηλότερο αλκύλιο], [OH, (C2-C5)alkenyl], [OH, (C2-C5)alkynyl] ή (C1-C6)alkylidene), όπου το εν λόγω alkyl, alkenyl, alkynyl και alkylidene είναι προαιρετικά αλογονομένο. ή =NOR5, όπου R5 είναι Η, χαμηλότερο αλκύλιο. Οι εστιγμένες γραμμές αντιπροσωπεύουν ένα προαιρετικό δεσμό, ή προφάρμακα για τη θεραπεία αρθριτικών παθήσεων και/ή αυτοάνοσων νόσων.
CY20061100629T 1999-11-29 2006-05-16 Παραγωγα στepοειδων του 3-μεθυλενιου για θepαπεια αυτοανοσων παθησεων CY1106088T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99204000 1999-11-29
EP00988758A EP1240179B1 (en) 1999-11-29 2000-11-23 3-methylene steroid derivatives for the treatment of autoimmune diseases
PCT/EP2000/011787 WO2001040253A2 (en) 1999-11-29 2000-11-23 3-methylene steroid derivative for the treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
CY1106088T1 true CY1106088T1 (el) 2011-06-08

Family

ID=8240918

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100629T CY1106088T1 (el) 1999-11-29 2006-05-16 Παραγωγα στepοειδων του 3-μεθυλενιου για θepαπεια αυτοανοσων παθησεων

Country Status (30)

Country Link
US (2) US6579864B1 (el)
EP (1) EP1240179B1 (el)
JP (1) JP2003517472A (el)
KR (1) KR100720326B1 (el)
CN (1) CN1254479C (el)
AR (1) AR033503A1 (el)
AT (1) ATE319732T1 (el)
AU (1) AU778773B2 (el)
BR (1) BR0015950A (el)
CA (1) CA2391096A1 (el)
CO (1) CO5251432A1 (el)
CY (1) CY1106088T1 (el)
CZ (1) CZ20021837A3 (el)
DE (1) DE60026608T2 (el)
DK (1) DK1240179T3 (el)
ES (1) ES2259624T3 (el)
HK (1) HK1047595B (el)
HU (1) HUP0203596A3 (el)
IL (2) IL149412A0 (el)
MX (1) MXPA02005334A (el)
NO (1) NO323136B1 (el)
NZ (1) NZ518756A (el)
PE (1) PE20010980A1 (el)
PL (1) PL355968A1 (el)
PT (1) PT1240179E (el)
RU (1) RU2248358C2 (el)
SK (1) SK285398B6 (el)
TW (1) TWI265167B (el)
WO (1) WO2001040253A2 (el)
ZA (1) ZA200203455B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives
EP1734998A2 (en) 2004-04-14 2006-12-27 Genentech, Inc. Compositions and methods comprising an egfl7 antagonist for modulating vascular development

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1085035A (en) * 1913-05-01 1914-01-20 George H Greimann Ditch-digging machine.
US1171221A (en) * 1915-12-13 1916-02-08 Charles Ephriam Marion Combination-tool.
US3213117A (en) * 1963-07-03 1965-10-19 Syntex Corp Process for preparation of delta1(10)-5alpha-estren-17beta-ol-2-one and derivatives thereof
BE654772A (el) * 1963-10-23
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
DE3560449D1 (en) 1984-03-29 1987-09-17 Ciba Geigy Ag Substituted 1-propanoles, process for their production, chloroformic-acid esters ad their use
GB8513723D0 (en) 1985-05-31 1985-07-03 Erba Farmitalia 11-beta substituted steroids
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives

Also Published As

Publication number Publication date
AR033503A1 (es) 2003-12-26
AU2508701A (en) 2001-06-12
SK7272002A3 (en) 2002-09-10
HUP0203596A3 (en) 2003-12-29
PL355968A1 (en) 2004-05-31
EP1240179A2 (en) 2002-09-18
PT1240179E (pt) 2006-05-31
US20040043972A1 (en) 2004-03-04
DE60026608D1 (de) 2006-05-04
IL149412A0 (en) 2002-11-10
KR20030024656A (ko) 2003-03-26
SK285398B6 (sk) 2007-01-04
NO20022521L (no) 2002-05-28
NZ518756A (en) 2004-05-28
WO2001040253A2 (en) 2001-06-07
BR0015950A (pt) 2002-11-12
HK1047595B (zh) 2006-05-04
TWI265167B (en) 2006-11-01
HK1047595A1 (en) 2003-02-28
WO2001040253A3 (en) 2002-05-02
CN1402734A (zh) 2003-03-12
JP2003517472A (ja) 2003-05-27
US6579864B1 (en) 2003-06-17
NO20022521D0 (no) 2002-05-28
CO5251432A1 (es) 2003-02-28
CA2391096A1 (en) 2001-06-07
PE20010980A1 (es) 2001-10-02
CN1254479C (zh) 2006-05-03
MXPA02005334A (es) 2003-04-10
IL149412A (en) 2007-07-24
KR100720326B1 (ko) 2007-05-22
DE60026608T2 (de) 2006-12-28
HUP0203596A2 (hu) 2003-02-28
DK1240179T3 (da) 2006-07-03
ES2259624T3 (es) 2006-10-16
EP1240179B1 (en) 2006-03-08
CZ20021837A3 (cs) 2002-08-14
AU778773B2 (en) 2004-12-23
NO323136B1 (no) 2007-01-08
ZA200203455B (en) 2004-04-28
RU2248358C2 (ru) 2005-03-20
ATE319732T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
CY1120081T1 (el) Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90
CY1105784T1 (el) Εκδοχα της πιπepαζινυλακυλπιπepιδινης η παρασκευη τους και η εφαρμογη τους στη θepαπευτικη
NO20074641L (no) 1-Acetic Acid-Indole Derivatives with PGD2 Antagonist Activity
NO20023823D0 (no) Fremgangsmåte for tilvirkning og bruk av pyrrolopyrimidinon- derivater
NO20054856D0 (no) 4-anilo-kinazolinderivater som antiproliferative midler
UY27597A1 (es) Inhibidores de acridona de la enzima impdh
CY1115533T1 (el) Παραγωγα χολικου οξεος ως προσδετες fxr για την προληψη ή τη θεραπευτικη αγωγη νοσηματων ή καταστασεων οι οποιες προκαλουνται με τη μεσολαβηση fxr
NO20032801L (no) Tiazolderivater for behandling av PPAR-relaterte forstyrrelser
RS51702B (en) 7- [2- [4- (6-Fluoro-3-methyl-1,2-benzisoxazol-5-yl) -1-piperazinyl] ethyl] -2- (1-propynyl) -7H-pyrazolo- [4. 3-e] - [1,2,4] -TRIAZOLO- [1,5-c] -PYRIMIDIN-5-AMIN
ATE397585T1 (de) Phenylsulfamat-derivate
KR950032267A (ko) 11,21-비스페닐-19-노르프레그난 유도체
NO20064031L (no) Esterderivater av thein og deres terapeutiske anvendelse
CY1106580T1 (el) Παραγωγα 5-(πυριδινιο-3-υλο)-1-αζαδικυκλο (3.2.1) οκτανιου, η διαδικασια παρασκευης και εφαρμογης τους στη θεραπευτικη
CY1106088T1 (el) Παραγωγα στepοειδων του 3-μεθυλενιου για θepαπεια αυτοανοσων παθησεων
AR034206A1 (es) Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
ECSP013947A (es) Compuestos estrogénicos
HUP0302527A2 (hu) Fungicid keverékek
ATE246703T1 (de) Oral wirksame 7-alpha-alkyl androgene
DK1282619T3 (da) Fremgangsmåde til fremstilling af thiazolidindionderivater og mellemprodukter
DK1196420T3 (da) Fremgangsmåde til syntese af beta-laktamderivater
DE602004016331D1 (de) Pentafluoroalkylsulfin-naphthaline und und darauf bezogene modulatoren des östrogenrezeptors
HUP0301741A2 (hu) Eljárás 4-bróm-anilin-származékok előállítására
ECSP951538A (es) Derivados de quinoxalina utiles en terapia
HUP0202296A2 (hu) Eljárás szubsztituált benzizotiazolszármazékok előállítására